A carregar...
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
OBJECTIVE: To assess the safety and efficacy of treatment with belimumab in patients with early diffuse cutaneous systemic sclerosis (dcSSc) treated with background mycophenolate mofetil (MMF). METHODS: In this 52-week, investigator-initiated, single-center, double-blind, placebo-controlled, pilot s...
Na minha lista:
| Publicado no: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590997/ https://ncbi.nlm.nih.gov/pubmed/29073351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40358 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|